medigraphic.com
ISSN 1561-2996 (Digital)
ISSN 0864-0289 (Impreso)

2013, Número 1

<< Anterior Siguiente >>

Rev Cubana Hematol Inmunol Hemoter 2013; 29 (1)


Inmunización del enfermo inmunocomprometido en Cuba. Consenso de criterios

Macías-Abraham C, Castro-Pacheco BL, González-Alemán M, Varcárcel-Sánchez M, Noda- Albelo A, Marsán-Suárez V, Sánchez-Segura M, Rodríguez-Hernández JF

Idioma: Español
Referencias bibliográficas: 28
Paginas: 48-58
Archivo PDF: 69.58 Kb.


RESUMEN

Los pacientes inmunocomprometidos con diagnóstico de inmunodeficiencia primaria secundaria a otras enfermedades y posterior a tratamiento inmunosupresor, como los corticoesteroides, la quimioterapia y el trasplante de células progenitoras hematopoyéticas, presentan riesgos particulares a la vacunación; es por ello que hay que considerar aspectos básicos como la susceptibilidad a contraer enfermedades infecciosas y su estado de inmunocompetencia. En este trabajo se presentan los criterios fundamentales para el manejo de la inmunización en el paciente inmunocomprometido en Cuba, como resultado del consenso entre diferentes especialidades médicas de nuestro Sistema Nacional de Salud (inmunología, pediatría, infectología, genética y hematología) con el Programa Nacional de Inmunización.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Immune Deficiency Foundation. Primary immune deficiency diseases in America: The second national survey of patients. 2002 [cited 2010 July 19]; Available from: http://www.primaryimmune.org/publications/surveys/secondnationalsurveyofpatients%282002%29.pdf

  2. Banks M. Deficient diagnosis. The Parliament. 2010;3 May:24-5.

  3. Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776-94.

  4. Immune Deficiency Foundation. About primary immunodeficiencies: what is a primary immunodeficiency disease? [cited 2010 July 5]; Available from: http://www.primaryimmune.org/aboutpi/about pi.htm

  5. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497-502.

  6. O'Mahony B. Rare diseases treated by plasma proteins. Pharmaceuticals Policy and Law. 2009;11:245-57.

  7. Espanol T. Primary immunodeficiencies. Pharmaceuticals Policy and Law. 2009;11:277-83.

  8. Yarmohammadi H, Estrella L, Doucette J, Cunningham-Rundles C. Recognizing primary immune deficiency in clinical practice. Clin Vaccine Immunol. 2006;13:329-32.

  9. Leiva LE, Bezrodnik L, Oleastro M, Condino-Neto A, Costa-Carvalho BT, Sevciovic Grumach A, et al. Sorensen. Primary immunodeficiency diseases in Latin America: Proceedings of the Second Latin American Society for Immunodeficiencies (LASID) Advisory borrad. Allergol Immunopathol (Madr). 2011;39(2):106-10.

  10. Maródi L, Casanova JL. Primary immunodeficiency diseases: the J Project. Lancet. 2009;373:2179-81.

  11. Pickett D, Modell V, Leighton I, Modell F. Impact of a physician education and patient awareness campaign on the diagnosis and management of primary immunodeficiencies. Immunol Res. 2008;40:93-4.

  12. Cooper MA, Pommering TL, Korányi K. Primary immunodeficiencies. Am Fam Physician. 2003;68:2001-8.

  13. Eades-Perner AM, Gathmann B, Knerr V, Guzman D, Veit D, Kindle G, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol. 2007;147:306-12.

  14. Ghazi BMS, Asghar Aghamohammadi A, Kouhi A, Farhoudi A, Moin M, Rezaei N, et al. Mortality in primary immunodeficient patients registered in Iranian primary immunodeficiency registry. Iran J Allergy Asthma Immunol. 2004;3:31-5.

  15. Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27:308-16.

  16. Seymour B, Miles J, Haeney M. Primary antibody deficiency and diagnostic delay. J Clin Pathol. 2005;58:546-7.

  17. Guías de manejo: vacunas en pacientes con inmunodeficiencias primarias. Grupo de Trabajo de Inmunología Pediátrica, Comité Nacional de Infectología y Subcomisión de Epidemiología. Arch Argent Pediatr. 2010;108(5):454-64.

  18. González M, Valcárcel M, Galindo MA. Inmunizaciones en Cuba. Rev Cubana Pediatr. 2009;81(Supl):48-52.

  19. Bazán V, Nolte F, Lamy P, Del Valle H, et al. Vacunas en huéspedes especiales. Rev Hosp Niños B Aires. 2005;47(214):278-88.

  20. The Pink Book. Epidemiology and prevention of vaccine preventable diseases. 10ª ed. The National Immunization Program. Center for Disease Control and Prevention. Atlanta; 2007.

  21. Stiehm ER, Ochs H, Winkelstein J. Immunologic disorders in infants and children. 5ª ed. Filadelfia: Elsevier Saunders; 2004.

  22. Royal College of Paediatrics and Child Health. Immunization of the immunocompromised child. Best Practice Statement. United Kingdom: Royal College of Paediatrics and Child Health; 2002. p. 6-9.

  23. American Academy of Pediatrics. Immunization in special clinical circumstances. Immunocompromised Children. En: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003. p. 69-81.

  24. Patel SR, Ortín M, Cohen BJ, Borrow R, Irving D, Sheldon, et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis. 2007:1;44(5):635-42.

  25. American Academy of Pediatrics. Immunization in special clinical circumstances. Immunocompromised Children. En: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006. p. 71-85.

  26. Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2006 December 1;55(RR-15).

  27. De la Cámara R, Bischofberger C, Campins M, Carrearas E. Immunización postrasplante de progenitores hematopoyéticos: revisión y recomendaciones. Med Clin (Barc). 1998;110:146-56.

  28. Adell C, Bayas JM, Vilella A, Perales M, Vidal J, Bertran MJ, et al. Vacunación de pacientes receptores de trasplante de progenitores hematopoyéticos. Med Clin (Barc). 2002;119:405-9.




2020     |     www.medigraphic.com